Mark Searcey

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Chemical communications (Cambridge, England)

Organic & biomolecular chemistry

Chemical science

RSC medicinal chemistry

University of East Anglia

University of Hertfordshire (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of East Anglia Apr 01 2019

United Kingdom

Pro Vice Chancellor of Science :: Pharmacy

Education History

University of Hertfordshire May 01 1986 - Apr 30 1989

United Kingdom

PHD :: Chemistry

Publications

Marco M D Cominetti, Zoë Rachael Goddard, Bethany R Hood, Andrew Michael Beekman, Maria A O'Connell, Mark Searcey
Borylation via iridium catalysed C-H activation: a new concise route to duocarmycin derivatives. Organic & biomolecular chemistry (2024)
Deanne Hayward, Zoë Rachael Goddard, Marco M D Cominetti, Mark Searcey, Andrew Michael Beekman
Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction. Chemical communications (Cambridge, England) 60 (63) (2024)
Marco M D Cominetti, Zoë Rachael Goddard, Bethany R Hood, Andrew Michael Beekman, Maria A O'Connell, Mark Searcey
Borylation via iridium catalysed C-H activation: a new concise route to duocarmycin derivatives. Organic & biomolecular chemistry 22 (27) (2024)
Deanne Hayward, Zoë Rachael Goddard, Marco M D Cominetti, Mark Searcey, Andrew Michael Beekman
Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction. Chemical communications (Cambridge, England) (2024)
Deanne Hayward, Zoë Rachael Goddard, Marco M D Cominetti, Mark Searcey, Andrew Michael Beekman
Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction. Chemical communications (Cambridge, England) 60 (63) (2024)
Deanne Hayward, Zoë Rachael Goddard, Marco M D Cominetti, Mark Searcey, Andrew Michael Beekman
Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction. Chemical communications (Cambridge, England) 60 (63) (2024)
Marco M D Cominetti, Zoë Rachael Goddard, Bethany R Hood, Andrew Michael Beekman, Maria A O'Connell, Mark Searcey
Borylation via iridium catalysed C-H activation: a new concise route to duocarmycin derivatives. Organic & biomolecular chemistry 22 (27) (2024)
Marco M D Cominetti, Zoë Rachael Goddard, Bethany R Hood, Andrew Michael Beekman, Maria A O'Connell, Mark Searcey
Borylation via iridium catalysed C-H activation: a new concise route to duocarmycin derivatives. Organic & biomolecular chemistry 22 (27) (2024)
Zoë Rachael Goddard, Andrew Michael Beekman, Marco M D Cominetti, Maria A O'Connell, Isabelle Chambrier, Michael J Cook, María J Marín, David A Russell, Mark Searcey
Peptide directed phthalocyanine-gold nanoparticles for selective photodynamic therapy of EGFR overexpressing cancers. RSC medicinal chemistry 12 (2) (2020)
Andrew Michael Beekman, Marco M D Cominetti, Oliver Charles Cartwright, Dale L Boger, Mark Searcey
A small molecule drug conjugate (SMDC) of DUPA and a duocarmycin built on the solid phase. MedChemComm 10 (12) (2019)
Andrew Michael Beekman, Marco M D Cominetti, Samuel J Walpole, Saurabh Prabhu, Maria A O'Connell, Jesus Angulo, Mark Searcey
Identification of selective protein-protein interaction inhibitors using efficient in silico peptide-directed ligand design. Chemical science 10 (16) (2019)

Mark Searcey.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mark Searcey